Abstract
Gene therapy is an attractive method for the treatment of cardiovascular disease. However, using current strategies, induction of gene expression at therapeutic levels is often inefficient. In this study, we show a novel electroporation (EP) method to enhance the delivery of a plasmid expressing an angiogenic growth factor (vascular endothelial growth factor, VEGF), which is a molecule previously documented to stimulate revascularization in coronary artery disease. DNA expression plasmids were delivered in vivo to the porcine heart with or without coadministered EP to determine the potential effect of electrically mediated delivery. The results showed that plasmid delivery through EP significantly increased cardiac expression of VEGF compared with injection of plasmid alone. This is the first report showing successful intracardiac delivery, through in vivo EP, of a protein expressing plasmid in a large animal.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mukherjee D, Bhatt DL, Roe MT, Patel V, Ellis SG . Direct myocardial revascularization and angiogenesis—how many patients might be eligible? Am J Cardiol 1999; 84: 598–600; A598.
Brewster L, Brey EM, Greisler HP . Cardiovascular gene delivery: the good road is awaiting. Adv Drug Deliv Rev 2006; 58: 604–629.
Fortuin FD, Vale P, Losordo DW, Symes J, DeLaria GA, Tyner JJ et al. One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients. Am J Cardiol 2003; 92: 436–439.
Grines CL, Watkins MW, Helmer G, Penny W, Brinker J, Marmur JD et al. Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation 2002; 105: 1291–1297.
Sarkar N, Ruck A, Kallner G, Y-Hassan S, Blomberg P, Islam KB et al. Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease–12-month follow-up: angiogenic gene therapy. J Intern Med 2001; 250: 373–381.
Stewart DJ, Hilton JD, Arnold JM, Gregoire J, Rivard A, Archer SL et al. Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Therapy 2006; 13: 1503–1511.
Dean DA . Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals. Am J Physiol Cell Physiol 2005; 289: C233–C245.
Schalch P, Rahman GF, Patejunas G, Goldschmidt RA, Carbray J, Retuerto MA et al. Adenoviral-mediated transfer of vascular endothelial growth factor 121 cDNA enhances myocardial perfusion and exercise performance in the nonischemic state. J Thorac Cardiovasc Surg 2004; 127: 535–540.
Herweijer H, Wolff JA . Progress and prospects: naked DNA gene transfer and therapy. Gene Therapy 2003; 10: 453–458.
Niidome T, Huang L . Gene therapy progress and prospects: nonviral vectors. Gene Therapy 2002; 9: 1647–1652.
Nishikawa M, Huang L . Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 2001; 12: 861–870.
Wells DJ . Gene therapy progress and prospects: electroporation and other physical methods. Gene Therapy 2004; 11: 1363–1369.
Caplen NJ, Alton EW, Middleton PG, Dorin JR, Stevenson BJ, Gao X et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med 1995; 1: 39–46.
Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987; 84: 7413–7417.
Nicolau C, Sene C . Liposome-mediated DNA transfer in eukaryotic cells. Dependence of the transfer efficiency upon the type of liposomes used and the host cell cycle stage. Biochim Biophys Acta 1982; 721: 185–190.
Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL . DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 1993; 90: 11478–11482.
Sun WH, Burkholder JK, Sun J, Culp J, Turner J, Lu XG et al. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc Natl Acad Sci USA 1995; 92: 2889–2893.
Yang NS, Burkholder J, Roberts B, Martinell B, McCabe D . In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci USA 1990; 87: 9568–9572.
Liu D, Knapp JE . Hydrodynamics-based gene delivery. Curr Opin Mol Ther 2001; 3: 192–197.
Liu F, Song Y, Liu D . Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy 1999; 6: 1258–1266.
Mir LM . Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry (Amsterdam, The Netherlands) 2001; 53: 1–10.
Aihara H, Miyazaki J . Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 1998; 16: 867–870.
Glasspool-Malone J, Somiari S, Drabick JJ, Malone RW . Efficient nonviral cutaneous transfection. Mol Ther 2000; 2: 140–146.
Heller LC, Heller R . In vivo electroporation for gene therapy. Hum Gene Ther 2006; 17: 890–897.
Lucas ML, Heller R . Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. Mol Ther 2001; 3: 47–53.
Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK et al. Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma. J Clin Oncol 2008; 26: 5896–5903.
Low L, Mander A, McCann KJ, Dearnaley D, Tjelle TE, Mathiesen I et al. DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum Gene Ther 2009; 20: 1269–1278.
Harrison RL, Byrne BJ, Tung L . Electroporation-mediated gene transfer in cardiac tissue. FEBS Lett 1998; 435: 1–5.
Thompson JF, Hayes LS, Lloyd DB . Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene 1991; 103: 171–177.
Takeshita S, Zheng LP, Brogi E, Kearney M, Pu L-Q, Bunting S et al. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994; 93: 662–670.
Lazarous DF, Shou M, Scheinowitz M, Hodge E, Thirumurti V, Kitsiou A et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 1996; 94: 1074–1082.
Hojman P, Gissel H, Andre FM, Cournil-Henrionnet C, Eriksen J, Gehl J et al. Physiological effects of high and low voltage pulse combinations for gene electrotransfer in muscle. Hum Gene Ther 2008; 19: 1249–1260.
Kastrup J, Jørgensen E, Rück A, Tägil K, Glogar D, Ruzyllo W et al. Direct intramyocardial plasmid vascular endothelial growth factor-a165 gene therapy in patients with stable severe angina pectoris. J Am Coll Cardiol 2005; 45: 982–988.
Gaffney MM, Hynes SO, Barry F, O’Brien T . Cardiovascular gene therapy: current status and therapeutic potential. Br J Pharmacol 2007; 152: 175–188.
Acknowledgements
This study was supported by a research grant from the National Institutes of Health R21 HL089017 and by the University of South Florida College of Medicine, Florida Center of Excellence for Biomolecular Identification and Targeted Therapeutics and Cook Medical, Inc.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Marshall, W., Boone, B., Burgos, J. et al. Electroporation-mediated delivery of a naked DNA plasmid expressing VEGF to the porcine heart enhances protein expression. Gene Ther 17, 419–423 (2010). https://doi.org/10.1038/gt.2009.153
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2009.153
Keywords
This article is cited by
-
Electroporation-mediated gene transfer directly to the swine heart
Gene Therapy (2013)
-
Cell-Specific Targeting Strategies for Electroporation-Mediated Gene Delivery in Cells and Animals
The Journal of Membrane Biology (2013)